BRANDY ARROL: Open Payments
NPI 1073804472 · EGLIN AFB, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$844 in 35 payments from 8 companies in 2025. Trend: 2023 $57 · 2024 $572 · 2025 $844
Food & beverage: $745Education: $99
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 19 | $408 |
| Janssen Biotech, Inc. | 8 | $245 |
| Antares Pharma, Inc. | 2 | $51 |
| PROGENICS PHARMACEUTICALS, INC. | 2 | $44 |
| IMMUNITYBIO, INC. | 1 | $34 |
| Endo USA, Inc. | 1 | $21 |
| Laborie Medical Technologies Corp. | 1 | $21 |
| 180 Medical, Inc. | 1 | $19 |
Products named: GEMTESA, ERLEADA, PYLARIFY, ANKTIVA, TLANDO, XYOSTED, XIAFLEX, Optilume BPH Drug Coated Balloon Catheter.
Industry payments across FL — which companies pay providers there.
